• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Gastrin Releasing Peptide, human

Gastrin Releasing Peptide, human

Product ID G0181
Cas No. 93755-85-2
Purity ≥95%
Product Unit SizeCostQuantityStock
1 mg $126.00 In stock
2.5 mg $252.00 In stock
5 mg $446.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Gastrin-releasing peptide (BB2) is an endogenous bombesin-like peptide that stimulates the release of gastrin by binding BB2 receptors; it is involved in feeding behavior (acting as an anorexigenic), circadian rhythms, and stress signaling. BB2 induces scratching behavior in vivo and exhibits pro-angiogenic activity in cancer models, inducing expression of IL-8 in a hepatocyte growth factor-dependent manner in gastric cancer cells.

Product Info

Cas No.

93755-85-2

Purity

≥95%

Formula

C130H204N38O31S2

Formula Wt.

2859.40

Synonym

GRP

Solubility

Soluble in water (1 mg/mL), DMSO.

Appearance

White to off-white Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G0181 MSDS PDF

Info Sheet

G0181 Info Sheet PDF

References

Kallingal GJ, Mintz EM. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus. Eur J Neurosci. 2014 Feb;39(4):630-9. PMID: 24528136.

Lee KH, Koh SA, Kim JR. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells. Oncol Res. 2013;20(9):393-402. PMID: 23924923.

Sukhtankar DD, Ko MC. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PLoS One. 2013 Jun 24;8(6):e67422. PMID: 23826298.

Merali Z, McIntosh J, Anisman H. Role of bombesin-related peptides in the control of food intake. Neuropeptides. 1999 Oct;33(5):376-86. PMID: 10657515.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T1855

    Tentoxin

    Cyclic peptide mycotoxin produced by Alternaria...

    ≥98%, HPLC
  • R5722

    Rofecoxib

    NSAID; COX-2 inhibitor.

    ≥98%
  • A5478

    Antipain Dihydrochloride

    Oligopeptide found in Actinomycetes; protease i...

  • P0398

    Pazufloxacin Methanesulfonate

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • T286161

    Theaflavin

    Polyphenolic compound present in black tea.

    ≥98%
  • G691343

    Griseofulvin

    Fungistatic

    ≥98%
  • A5031

    4-Aminophenylphosphate Disodium

    Alkaline phosphatase substrate used to quantify...

    ≥98%
  • L8276

    Luteinizing Hormone Releasing Hormone

    Endogenous peptide hormone; GnRH agonist.

    ≥98%
  • M5877

    Motesanib Diphosphate

    VEGFR, PDGFR, c-Kit, RET inhibitor.

    ≥98%
  • T3203

    Tianeptine Sodium Hydrate

    μOR and δOR agonist, D2/D3 DA potentiator.

    ≥98%
  • G4797

    GLYX-13 Trifluoroacetate

    Peptide; NMDA partial agonist.

    ≥98%
  • P1622

    Pefloxacin Methanesulfonate Dihydrate

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • C2916

    Chenodeoxycholic Acid

    Endogenous bile acid; FXR agonist.

    ≥98%
  • G1646

    Geldanamycin

    HSP90 inhibitor.

    ≥97%
  • C0016

    Caerulomycin A

    Bipyridamine toxin.

    ≥96%
  • A064766

    ABT 639

    T-type calcium channel blocker

    ≥99%
  • A1332

    Adipokinetic Hormone II from Locusta migratoria

    Neuropeptide found in Locusta migratoria.

    ≥98%
  • T7135

    Triticonazole

    Triazole; 14-α demethylase inhibitor, potentia...

    ≥95%
  • N7604

    Naltriben

    δ2OR antagonist.

    ≥95%
  • G8850

    GW-5074

    c-Raf inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only